APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insulin Like Growth Factor 1 Receptor Industry Growth and Trends Forecast to 2032

Report ID 174003610119 December 2025118 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor 1 Receptor Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor 1 Receptor Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor 1 Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor 1 Receptor Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor 1 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Like Growth Factor 1 Receptor include Novartis AG, Merck & Co., Inc., Eli Lilly and Company, AstraZeneca Plc, ProteoThera, Inc., PharmAbcine, Inc., Merrimack Pharmaceuticals, Inc., Insmed Incorporated and Immunomedics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Like Growth Factor 1 Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Like Growth Factor 1 Receptor market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Like Growth Factor 1 Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Like Growth Factor 1 Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Like Growth Factor 1 Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Like Growth Factor 1 Receptor Market by Company

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

AstraZeneca Plc

ProteoThera, Inc.

PharmAbcine, Inc.

Merrimack Pharmaceuticals, Inc.

Insmed Incorporated

Immunomedics, Inc.

Genmab A/S

F. Hoffmann-La Roche Ltd.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Axelar AB

Astellas Pharma Inc.

Insulin Like Growth Factor 1 Receptor Segment by Type

CT-707

BI-893923

ATL-1101

1R-E1

Others

Insulin Like Growth Factor 1 Receptor Segment by Application

Hospital

Clinic

Others

Insulin Like Growth Factor 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Like Growth Factor 1 Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Like Growth Factor 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CT-707 Table 2. Major Company of BI-893923 Table 3. Major Company of ATL-1101 Table 4. Major Company of 1R-E1 Table 5. Major Company of Others Table 6. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 8. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type (2021-2026) Table 9. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 10. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type (2021-2026) Table 11. Global Insulin Like Growth Factor 1 Receptor Price by Type (2021-2026) & (US$/Unit) Table 12. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 13. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type (2027-2032) Table 14. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (US$ Million) Table 15. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type (2027-2032) Table 16. Global Insulin Like Growth Factor 1 Receptor Price by Type (2027-2032) & (US$/Unit) Table 17. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 18. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 20. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 24. Latin America Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 27. Insulin Like Growth Factor 1 Receptor Industry Trends Table 28. Insulin Like Growth Factor 1 Receptor Industry Drivers Table 29. Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges Table 30. Insulin Like Growth Factor 1 Receptor Industry Restraints Table 31. Global Insulin Like Growth Factor 1 Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Company (2021-2026) Table 33. Global Insulin Like Growth Factor 1 Receptor Sales by Company (2021-2026) & (W Units) Table 34. Global Insulin Like Growth Factor 1 Receptor Sales Share by Company (2021-2026) Table 35. Global Insulin Like Growth Factor 1 Receptor Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Insulin Like Growth Factor 1 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Insulin Like Growth Factor 1 Receptor Major Company Production Sites and Headquarters Table 38. Global Insulin Like Growth Factor 1 Receptor Company, Product Type & Application Table 39. Global Insulin Like Growth Factor 1 Receptor Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Insulin Like Growth Factor 1 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Insulin Like Growth Factor 1 Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026) & (W Units) Table 44. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Region (2021-2026) Table 45. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026) & (US$ Million) Table 46. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Region (2021-2026) Table 47. Global Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032) & (W Units) Table 49. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Region (2027-2032) Table 50. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032) & (US$ Million) Table 51. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Region (2027-2032) Table 52. Global Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 55. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application (2021-2026) Table 56. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 57. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application (2021-2026) Table 58. Global Insulin Like Growth Factor 1 Receptor Price by Application (2021-2026) & (US$/Unit) Table 59. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 60. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application (2027-2032) Table 61. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (US$ Million) Table 62. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application (2027-2032) Table 63. Global Insulin Like Growth Factor 1 Receptor Price by Application (2027-2032) & (US$/Unit) Table 64. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 65. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 67. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 71. Latin America Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio Table 78. Novartis AG Recent Development Table 79. Merck & Co., Inc. Company Information Table 80. Merck & Co., Inc. Business Overview Table 81. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 83. Merck & Co., Inc. Recent Development Table 84. Eli Lilly and Company Company Information Table 85. Eli Lilly and Company Business Overview Table 86. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 88. Eli Lilly and Company Recent Development Table 89. AstraZeneca Plc Company Information Table 90. AstraZeneca Plc Business Overview Table 91. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio Table 93. AstraZeneca Plc Recent Development Table 94. ProteoThera, Inc. Company Information Table 95. ProteoThera, Inc. Business Overview Table 96. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 98. ProteoThera, Inc. Recent Development Table 99. PharmAbcine, Inc. Company Information Table 100. PharmAbcine, Inc. Business Overview Table 101. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 103. PharmAbcine, Inc. Recent Development Table 104. Merrimack Pharmaceuticals, Inc. Company Information Table 105. Merrimack Pharmaceuticals, Inc. Business Overview Table 106. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 108. Merrimack Pharmaceuticals, Inc. Recent Development Table 109. Insmed Incorporated Company Information Table 110. Insmed Incorporated Business Overview Table 111. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio Table 113. Insmed Incorporated Recent Development Table 114. Immunomedics, Inc. Company Information Table 115. Immunomedics, Inc. Business Overview Table 116. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 118. Immunomedics, Inc. Recent Development Table 119. Genmab A/S Company Information Table 120. Genmab A/S Business Overview Table 121. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio Table 123. Genmab A/S Recent Development Table 124. F. Hoffmann-La Roche Ltd. Company Information Table 125. F. Hoffmann-La Roche Ltd. Business Overview Table 126. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 128. F. Hoffmann-La Roche Ltd. Recent Development Table 129. Bristol-Myers Squibb Company Company Information Table 130. Bristol-Myers Squibb Company Business Overview Table 131. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 133. Bristol-Myers Squibb Company Recent Development Table 134. Boehringer Ingelheim GmbH Company Information Table 135. Boehringer Ingelheim GmbH Business Overview Table 136. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio Table 138. Boehringer Ingelheim GmbH Recent Development Table 139. Axelar AB Company Information Table 140. Axelar AB Business Overview Table 141. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio Table 143. Axelar AB Recent Development Table 144. Astellas Pharma Inc. Company Information Table 145. Astellas Pharma Inc. Business Overview Table 146. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 148. Astellas Pharma Inc. Recent Development Table 149. North America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 150. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 151. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2026) Table 152. North America Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 153. North America Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 154. North America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 156. North America Insulin Like Growth Factor 1 Receptor Market Share by Country (2021-2026) Table 157. North America Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America Insulin Like Growth Factor 1 Receptor Market Share Forecast by Country (2027-2032) Table 159. Europe Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 160. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 161. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2026) Table 162. Europe Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 163. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 164. Europe Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe Insulin Like Growth Factor 1 Receptor Market Share by Country (2021-2026) Table 167. Europe Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe Insulin Like Growth Factor 1 Receptor Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 171. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 173. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Share by Country (2021-2026) Table 177. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Share Forecast by Country (2027-2032) Table 179. Latin America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 180. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 181. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2026) Table 182. Latin America Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 183. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America Insulin Like Growth Factor 1 Receptor Market Share by Country (2021-2026) Table 187. Latin America Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America Insulin Like Growth Factor 1 Receptor Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 191. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 193. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Share by Country (2021-2026) Table 197. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Insulin Like Growth Factor 1 Receptor Distributors List Table 202. Insulin Like Growth Factor 1 Receptor Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Insulin Like Growth Factor 1 Receptor Image Figure 2. Global Insulin Like Growth Factor 1 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Like Growth Factor 1 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Like Growth Factor 1 Receptor Sales (2021-2032) & (W Units) Figure 5. CT-707 Image Figure 6. Global CT-707 Sales YoY Growth (2021-2032) & (W Units) Figure 7. BI-893923 Image Figure 8. Global BI-893923 Sales YoY Growth (2021-2032) & (W Units) Figure 9. ATL-1101 Image Figure 10. Global ATL-1101 Sales YoY Growth (2021-2032) & (W Units) Figure 11. 1R-E1 Image Figure 12. Global 1R-E1 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Insulin Like Growth Factor 1 Receptor Market Share by Type 2025 VS 2032 Figure 17. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 18. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2025 Figure 19. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 20. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2025 Figure 23. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Insulin Like Growth Factor 1 Receptor Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Insulin Like Growth Factor 1 Receptor Market Share by Application 2025 VS 2032 Figure 37. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 38. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2025 Figure 39. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 40. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2025 Figure 43. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2025 Figure 47. North America Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Insulin Like Growth Factor 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Insulin Like Growth Factor 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Insulin Like Growth Factor 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Insulin Like Growth Factor 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Insulin Like Growth Factor 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Insulin Like Growth Factor 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Insulin Like Growth Factor 1 Receptor Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Insulin Like Growth Factor 1 Receptor Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CT-707
  • BI-893923
  • ATL-1101
  • 1R-E1
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca Plc
  • ProteoThera, Inc.
  • PharmAbcine, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Insmed Incorporated
  • Immunomedics, Inc.
  • Genmab A/S
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Axelar AB
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Like Growth Factor 1 Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Like Growth Factor 1 Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Like Growth Factor 1 Receptor Market by Type
  6. 1.3.1 CT-707
  7. 1.3.2 BI-893923
  8. 1.3.3 ATL-1101
  9. 1.3.4 1R-E1
  10. 1.3.5 Others
  11. 1.4 Global Insulin Like Growth Factor 1 Receptor Market Size by Type
  12. 1.4.1 Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Insulin Like Growth Factor 1 Receptor Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Like Growth Factor 1 Receptor Industry Trends
  2. 2.2 Insulin Like Growth Factor 1 Receptor Industry Drivers
  3. 2.3 Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges
  4. 2.4 Insulin Like Growth Factor 1 Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Like Growth Factor 1 Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Like Growth Factor 1 Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Like Growth Factor 1 Receptor Price (2021-2026)
  4. 3.4 Global Insulin Like Growth Factor 1 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Like Growth Factor 1 Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Like Growth Factor 1 Receptor Company, Product Type & Application
  7. 3.7 Global Insulin Like Growth Factor 1 Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Like Growth Factor 1 Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Like Growth Factor 1 Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Like Growth Factor 1 Receptor Tier 1, Tier 2, and Tier 3
4 Insulin Like Growth Factor 1 Receptor Regional Status and Outlook
  1. 4.1 Global Insulin Like Growth Factor 1 Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Like Growth Factor 1 Receptor Historic Market Size by Region
  3. 4.2.1 Global Insulin Like Growth Factor 1 Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Like Growth Factor 1 Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Like Growth Factor 1 Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Like Growth Factor 1 Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Like Growth Factor 1 Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Like Growth Factor 1 Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Like Growth Factor 1 Receptor by Application
  1. 5.1 Insulin Like Growth Factor 1 Receptor Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Insulin Like Growth Factor 1 Receptor Market Size by Application
  6. 5.2.1 Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Insulin Like Growth Factor 1 Receptor Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 AstraZeneca Plc
  20. 6.4.1 AstraZeneca Plc Company Information
  21. 6.4.2 AstraZeneca Plc Business Overview
  22. 6.4.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio
  24. 6.4.5 AstraZeneca Plc Recent Developments
  25. 6.5 ProteoThera, Inc.
  26. 6.5.1 ProteoThera, Inc. Company Information
  27. 6.5.2 ProteoThera, Inc. Business Overview
  28. 6.5.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  30. 6.5.5 ProteoThera, Inc. Recent Developments
  31. 6.6 PharmAbcine, Inc.
  32. 6.6.1 PharmAbcine, Inc. Company Information
  33. 6.6.2 PharmAbcine, Inc. Business Overview
  34. 6.6.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  36. 6.6.5 PharmAbcine, Inc. Recent Developments
  37. 6.7 Merrimack Pharmaceuticals, Inc.
  38. 6.7.1 Merrimack Pharmaceuticals, Inc. Company Information
  39. 6.7.2 Merrimack Pharmaceuticals, Inc. Business Overview
  40. 6.7.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  42. 6.7.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  43. 6.8 Insmed Incorporated
  44. 6.8.1 Insmed Incorporated Company Information
  45. 6.8.2 Insmed Incorporated Business Overview
  46. 6.8.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio
  48. 6.8.5 Insmed Incorporated Recent Developments
  49. 6.9 Immunomedics, Inc.
  50. 6.9.1 Immunomedics, Inc. Company Information
  51. 6.9.2 Immunomedics, Inc. Business Overview
  52. 6.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  54. 6.9.5 Immunomedics, Inc. Recent Developments
  55. 6.10 Genmab A/S
  56. 6.10.1 Genmab A/S Company Information
  57. 6.10.2 Genmab A/S Business Overview
  58. 6.10.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio
  60. 6.10.5 Genmab A/S Recent Developments
  61. 6.11 F. Hoffmann-La Roche Ltd.
  62. 6.11.1 F. Hoffmann-La Roche Ltd. Company Information
  63. 6.11.2 F. Hoffmann-La Roche Ltd. Business Overview
  64. 6.11.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio
  66. 6.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
  67. 6.12 Bristol-Myers Squibb Company
  68. 6.12.1 Bristol-Myers Squibb Company Company Information
  69. 6.12.2 Bristol-Myers Squibb Company Business Overview
  70. 6.12.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 6.13 Boehringer Ingelheim GmbH
  74. 6.13.1 Boehringer Ingelheim GmbH Company Information
  75. 6.13.2 Boehringer Ingelheim GmbH Business Overview
  76. 6.13.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio
  78. 6.13.5 Boehringer Ingelheim GmbH Recent Developments
  79. 6.14 Axelar AB
  80. 6.14.1 Axelar AB Company Information
  81. 6.14.2 Axelar AB Business Overview
  82. 6.14.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio
  84. 6.14.5 Axelar AB Recent Developments
  85. 6.15 Astellas Pharma Inc.
  86. 6.15.1 Astellas Pharma Inc. Company Information
  87. 6.15.2 Astellas Pharma Inc. Business Overview
  88. 6.15.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  90. 6.15.5 Astellas Pharma Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Like Growth Factor 1 Receptor Sales by Country
  2. 7.1.1 North America Insulin Like Growth Factor 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Like Growth Factor 1 Receptor Market Size by Country
  6. 7.2.1 North America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Like Growth Factor 1 Receptor Sales by Country
  2. 8.1.1 Europe Insulin Like Growth Factor 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Like Growth Factor 1 Receptor Market Size by Country
  6. 8.2.1 Europe Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Like Growth Factor 1 Receptor Sales by Country
  2. 10.1.1 South America Insulin Like Growth Factor 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Like Growth Factor 1 Receptor Market Size by Country
  6. 10.2.1 South America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Like Growth Factor 1 Receptor Value Chain Analysis
  2. 12.1.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Like Growth Factor 1 Receptor Production Mode & Process
  7. 12.2 Insulin Like Growth Factor 1 Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Like Growth Factor 1 Receptor Distributors
  10. 12.2.3 Insulin Like Growth Factor 1 Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst